Making Sense of Novartis and GlaxoSmithKline's Web of Deals - Presented by: The Aol. On Network

The pharmaceutical industry had a deluge of M&A activity on Tuesday as heavyweights Novartis and GlaxoSmithKline announced they were trading $20 billion worth of assets. Novartis will purchase GSK's oncology portfolio for $14.5 billion, strengthening its number two spot in the specialty. Meanwhile, GSK will purchase Novartis' vaccines unit for $5.25 billion. The two companies will also form a separate consumer healthcare business in which GSK will hold a 63.5 percent majority stake.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AMAT $ 20.165 1.64 ▼ 7.50%
VALE $ 8.10 0.18 ▲ 2.27%
PBR $ 9.591 0.40 ▼ 3.99%
AAPL $ 132.7453 2.47 ▲ 1.89%
MSFT $ 47.85 0.02 ▼ 0.04%
BAC $ 15.69 0.05 ▲ 0.32%
CLDN $ 2.815 10.87 ▼ 79.42%
TSM $ 25.4699 0.56 ▲ 2.25%

As of 4/27/2015, 12:03 PM